NAVIO
Navio Theragnostics, Inc.
Application Filed: 2018-01-19
Trademark Application Details
REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87763013 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Brian R. Coleman |
| Attorney Docket Number | 125777-4001 |
| Law Office Assigned | N20 |
| Employee Name | JOHNSON, DANYTHE ELIZA |
Timeline
| 2018-01-19 | Application Filed |
| 2019-06-19 | Location: TMO LAW OFFICE 120 |
| 2019-06-19 | Status: Live/Pending |
| 2019-06-19 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Navio Theragnostics, Inc. |
| Address | 149 A Elm Street San Mateo DE 94401 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 36 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0351 | Pharmaceutical procurement services, namely, purchasing pharmaceuticals for others; pharmaceutical cost management services and drug utilization review services; assisting patients in enrolling in diagnostics and pharmaceutical reimbursement programs of others; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of diagnostics reimbursement for providers and patients; business administration of diagnostics and pharmacy reimbursement programs and services; business management and consultation services in the field of specialty pharmacy, namely, assisting patients and providers with pharmaceutical reimbursement; business management and consultation services in the field of off label pharmaceuticals, namely, assisting patients and providers with pharmaceutical reimbursement; business management services in the field of diagnostics, namely, assisting patients and providers with diagnostics reimbursement; and promoting collaboration within the scientific, research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals; business management of comprehensive programs involving drug therapy; providing personalized molecular tumor for each patient, namely, treatment services featuring personalized molecular tumors for patients; developing and managing comprehensive treatment programs involving drug therapy, namely, business management of comprehensive treatment programs involving drug therapy |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-01-23 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-01-31 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-04-30 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-05-08 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-05-08 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-05-08 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-11-07 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-11-07 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-11-08 | 9 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2018-11-29 | 10 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2018-11-29 | 11 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2018-11-29 | 12 GNS3 O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2019-06-14 | 13 ALIE A:Allowance for Publication |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2019-06-19 | 14 RCSC S: |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2020-01-24 | 15 RCCK S: |
| FINAL REFUSAL WRITTEN | 2020-02-18 | 16 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2020-02-18 | 17 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2020-02-18 | 18 GNFN O:Outgoing Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2020-08-12 | 19 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2020-08-12 | 20 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2020-08-12 | 21 EXPI T:TTAB Proceeding |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2020-08-12 | 22 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-08-15 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-08-15 | 24 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2020-09-03 | 25 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2020-09-03 | 26 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-09-03 | 27 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2020-09-03 | 28 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-09-14 | 29 CNSA P: |
| EXPARTE APPEAL TERMINATED | 2020-09-14 | 30 EXPT T:TTAB Proceeding |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-09-30 | 31 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2020-10-20 | 32 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-10-20 | 33 NPUB E:E-Mail |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2020-11-13 | 34 ETOF T:TTAB Proceeding |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2020-12-30 | 35 ETOP T:TTAB Proceeding |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-02-09 | 36 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2021-08-05 | 37 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2021-08-05 | 38 EXT1 S: |
| EXTENSION 1 GRANTED | 2021-08-05 | 39 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-08-07 | 40 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-02-09 | 41 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2022-02-09 | 42 EXT2 S: |
| EXTENSION 2 GRANTED | 2022-02-09 | 43 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-02-11 | 44 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2022-08-08 | 45 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2022-08-08 | 46 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2022-08-08 | 47 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-08-10 | 48 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2023-01-31 | 49 EEXT I:Incoming Correspondence |
| SOU EXTENSION 4 FILED | 2023-01-31 | 50 EXT4 S: |
| SOU EXTENSION 4 GRANTED | 2023-01-31 | 51 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-02-02 | 52 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2023-09-11 | 53 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2023-09-11 | 54 MAB6 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 